Paul J. Mellett
2013
In 2013, Paul J. Mellett earned a total compensation of $924.2K as Senior Vice President, Finance & Administration and Chief Financial Officer at Enanta Pharmaceuticals, a 101% increase compared to previous year.
Compensation breakdown
Bonus | $114,603 |
---|---|
Option Awards | $499,527 |
Salary | $305,624 |
Other | $4,439 |
Total | $924,193 |
Mellett received $499.5K in option awards, accounting for 54% of the total pay in 2013.
Mellett also received $114.6K in bonus, $305.6K in salary and $4.4K in other compensation.
Rankings
In 2013, Paul J. Mellett's compensation ranked 6,981st out of 12,286 executives tracked by ExecPay. In other words, Mellett earned more than 43.2% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 6,981 | 43rd |
Manufacturing | 2,476 | 46th |
Chemicals And Allied Products | 756 | 48th |
Drugs | 559 | 52nd |
Pharmaceutical Preparations | 443 | 50th |
Mellett's colleagues
We found two more compensation records of executives who worked with Paul J. Mellett at Enanta Pharmaceuticals in 2013.
News
Enanta Pharmaceuticals CEO Jay Luly's 2022 pay jumps 37% to $7.3M
January 20, 2023
Enanta Pharmaceuticals CEO Jay Luly's 2021 pay rises 2% to $5.3M
January 21, 2022
Enanta Pharmaceuticals CEO Jay Luly's 2020 pay rises 16% to $5.2M
January 21, 2021
Enanta Pharmaceuticals CEO Jay Luly's 2019 pay slips 1% to $4.5M
January 17, 2020
Enanta Pharmaceuticals CEO Jay Luly's 2018 pay rises 5% to $4.5M
January 18, 2019